Answer
The SRRR-enantiomer (d-nebivolol) is responsible for nebivolol hydrochloride’s competitive and selective beta-receptor blocking activity.
Sources for this answer
- Nebilet 5mg TabletsA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §5.1 Pharmacodynamic properties · Version 13Document updated
Sources checked